NovelStem International (NSTM) Stock Price, News & Analysis

Company Overview

NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

Key Stats

• Today's Range: $0.02 to $0.02
• 50-Day Range: $0.01 to $0.04
• 52-Week Range: $0.01 to $0.06
• Volume: N/A
• Average Volume: 1,744 shs
• Market Capitalization: $1.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NSTM Stock Analysis - Frequently Asked Questions

How have NSTM shares performed this year?

NovelStem International's stock was trading at $0.0078 at the start of the year. Since then, NSTM shares have increased by 191.0% and is now trading at $0.0227.

How do I buy shares of NovelStem International?

Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NovelStem International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NovelStem International investors own include Pure Gold Mining (PGM), Osisko Mining (OBNNF), New Gold (NGD), Pure Gold Mining (LRTNF), Hecla Mining (HL), GSE Systems (GVP) and Granada Gold Mine (GGM).

Company Calendar

• Today: 7/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:NSTM
• CIK: 912544
• Web: www.novelstem.com
• Phone: 410-654-3315
• Fax: 561-998-2974
• Employees: 15
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$3.23 million
• Net Margins: -26,941.67%
• Pretax Margin: -33,655.55%
• Return on Equity: N/A
• Return on Assets: -440.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $10 thousand
• Price / Sales: 106.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.11) per share
• Price / Book: -0.21

Miscellaneous

• Outstanding Shares: 46,880,000
• Free Float: 40,486,000
• Market Cap: $1.06 million
• Optionable: Not Optionable
• Beta: 2.14